BioRestorative Therapies (FRA:9OF) Total Liabilities: €1.40 Mil (As of Mar. 2026)

What is BioRestorative Therapies Total Liabilities?

BioRestorative Therapies FRA:9OF -3.68% 51 Total Liabilities is €1.40 Mil as of Mar. 2026. GuruFocus rates FRA:9OF with a GF Score™ of 51/100 and a GF Value™ of €1.26 (Possible Value Trap). The stock has 3 warning signs investors should review.

BioRestorative Therapies's Total Liabilities for the quarter that ended in Mar. 2026 was €1.40 Mil.

BioRestorative Therapies's quarterly Total Liabilities increased from Sep. 2025 (€2.93 Mil) to Dec. 2025 (€3.18 Mil) but then declined from Dec. 2025 (€3.18 Mil) to Mar. 2026 (€1.40 Mil).

BioRestorative Therapies's annual Total Liabilities increased from Dec. 2023 (€2.39 Mil) to Dec. 2024 (€3.58 Mil) but then declined from Dec. 2024 (€3.58 Mil) to Dec. 2025 (€3.18 Mil).

BioRestorative Therapies Total Liabilities Related Terms

BioRestorative Therapies Total Liabilities Historical Data

* Premium members only.

The historical data trend for BioRestorative Therapies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioRestorative Therapies Total Liabilities Chart

BioRestorative Therapies Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

0.76

5.80

2.39

3.58

3.18

BioRestorative Therapies Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Liabilities	Get a 7-Day Free Trial															3.87	3.18	2.93	3.18	1.40

51GF Score

BioRestorative Therapies Inc FRA:9OF

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BioRestorative Therapies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BioRestorative Therapies's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.179	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	3.18

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	3.484	-	0.305
	=	3.18

BioRestorative Therapies's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.397	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	1.40

Total Liabilities	=	Total Assets (Q: Mar. 2026 )	-	Total Equity (Q: Mar. 2026 )
	=	4.014	-	2.617
	=	1.40

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of €1.40 Mil mean?

BioRestorative Therapies (FRA:9OF) has a Total Liabilities of €1.40 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BioRestorative Therapies and its competitors.

Is BioRestorative Therapies' Total Liabilities too high?

BioRestorative Therapies' current Total Liabilities is €1.40 Mil. Overall, BioRestorative Therapies has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does BioRestorative Therapies' Total Liabilities compare to CVKD and JSPR?

BioRestorative Therapies' Total Liabilities of €1.40 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Biotechnology company?

A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BioRestorative Therapies and its competitors. BioRestorative Therapies's current Total Liabilities is €1.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BioRestorative Therapies stock overvalued right now?

Based on GuruFocus' analysis, BioRestorative Therapies (FRA:9OF) is currently considered Possible Value Trap. The stock's GF Value™ is €1.26, compared to a current price of €0.31 — trading 75.1% below its estimated fair value. The current Total Liabilities is €1.40 Mil. BioRestorative Therapies' overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For BioRestorative Therapies (FRA:9OF), the current Total Liabilities is €1.40 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioRestorative Therapies (FRA:9OF) Overvalued in 2026?

Based on GuruFocus' analysis, BioRestorative Therapies stock appears to be undervalued. The current stock price of €0.31 is trading 75.1% below its estimated GF Value™ of €1.26. GuruFocus considers BioRestorative Therapies to be Possible Value Trap.

Key valuation signals for FRA:9OF:

Total Liabilities: €1.40 Mil
GF Value™: €1.26 vs. price of €0.31 (75.1% below fair value)
GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the FRA:9OF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioRestorative Therapies Business Description

Industry Healthcare Biotechnology

Comparable Companies CVKD JSPR APRE RVPH AIM BCLI ADAPY BOLT ERNA PMCB VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges BRTX:USA

Address 40 Marcus Drive, Suite One, Melville, NY, USA, 11747

Website https://www.biorestorative.com

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

51GF Score

Get the complete analysis for FRA:9OF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.31

Price

€1.26

GF Value

View FRA:9OF Analysis

See Total Liabilities data for all stocks →